Literature DB >> 29363071

LC-MS/MS Analysis of the Epoxides and Diols Derived from the Endocannabinoid Arachidonoyl Ethanolamide.

Amy A Rand1, Patrick O Helmer2, Bora Inceoglu1, Bruce D Hammock1, Christophe Morisseau3.   

Abstract

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is a useful tool to characterize the behavior of natural lipids within biological matrices. We report a LC-MS/MS method developed specifically to analyze CYP products of the arachidonoyl ethanolamide (anandamide, AEA), the epoxyeicosatrienoic acid ethanolamides (EET-EAs) and their hydrolyzed metabolites, and the dihydroxyeicosatrienoic acid ethanolamides (DHET-EAs). This method was used to measure EET-EA biotransformation to DHET-EAs by two human epoxide hydrolases: the soluble EH (sEH) and the microsomal EH (mEH). In general, sEH and mEH substrate preference was similar, based on kcat/KM. The 14,15-EET-EA and 11,12-EET-EA were the most efficiently hydrolyzed, followed by 8,9-EET-EA and 5,6-EET-EA. The method was also used to detect endogenous levels of these lipids in mouse tissues, although levels were below the instrumental detection limit (0.1-3.4 nM). Because both AEA and EETs are biologically active, the method described herein will be invaluable in revealing the role(s) of EET-EAs in vivo.

Entities:  

Keywords:  Anandamide; Bioactivity; CYP450; DHET-EAs; EET-EAs; Enzyme kinetics; Epoxide hydrolase; Limit of -detection; Liquid chromatography mass spectrometry

Mesh:

Substances:

Year:  2018        PMID: 29363071      PMCID: PMC5831730          DOI: 10.1007/978-1-4939-7592-1_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.

Authors:  Chitra Sridar; Natasha T Snider; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2011-02-02       Impact factor: 3.922

2.  Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides.

Authors:  Natasha T Snider; Andrei M Kornilov; Ute M Kent; Paul F Hollenberg
Journal:  J Pharmacol Exp Ther       Date:  2007-02-01       Impact factor: 4.030

Review 3.  The endocannabinoid system and the brain.

Authors:  Raphael Mechoulam; Linda A Parker
Journal:  Annu Rev Psychol       Date:  2012-07-12       Impact factor: 24.137

4.  Development of fluorescent substrates for microsomal epoxide hydrolase and application to inhibition studies.

Authors:  Christophe Morisseau; Maud Bernay; Aurélie Escaich; James R Sanborn; Jozsef Lango; Bruce D Hammock
Journal:  Anal Biochem       Date:  2011-03-01       Impact factor: 3.365

Review 5.  Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception.

Authors:  Karen Wagner; Bora Inceoglu; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-08-10       Impact factor: 3.072

Review 6.  Epoxyeicosatrienoic acid pathway in human health and diseases.

Authors:  Jeremy Bellien; Robinson Joannides
Journal:  J Cardiovasc Pharmacol       Date:  2013-03       Impact factor: 3.105

Review 7.  Endocannabinoid metabolism by cytochrome P450 monooxygenases.

Authors:  Susan Zelasko; William R Arnold; Aditi Das
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-11-24       Impact factor: 3.072

8.  Effect of soluble epoxide hydrolase polymorphism on substrate and inhibitor selectivity and dimer formation.

Authors:  Christophe Morisseau; Aaron T Wecksler; Catherine Deng; Hua Dong; Jun Yang; Kin Sing S Lee; Sean D Kodani; Bruce D Hammock
Journal:  J Lipid Res       Date:  2014-04-27       Impact factor: 5.922

9.  Microsomal cytochrome P450-mediated liver and brain anandamide metabolism.

Authors:  L M Bornheim; K Y Kim; B Chen; M A Correia
Journal:  Biochem Pharmacol       Date:  1995-08-25       Impact factor: 5.858

Review 10.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

View more
  2 in total

Review 1.  Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases.

Authors:  Jogen Atone; Karen Wagner; Kenji Hashimoto; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-11-05       Impact factor: 3.072

2.  Relative Importance of Soluble and Microsomal Epoxide Hydrolases for the Hydrolysis of Epoxy-Fatty Acids in Human Tissues.

Authors:  Christophe Morisseau; Sean D Kodani; Shizuo G Kamita; Jun Yang; Kin Sing Stephen Lee; Bruce D Hammock
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.